Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aleafia Health Inc ALEAF

Aleafia Health Inc. is a Canada-based cannabis company. The Company offers cannabis products in Canada and destined for international markets, including Australia and Germany. The Company operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners, which provide health and wellness services across Canada. It owns three licensed cannabis production facilities and operates a located distribution center all in the province of Ontario, including an outdoor cannabis cultivation facility in Canada. The Company produces a diverse portfolio of cannabis and cannabis derivative products, including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips, and topicals, for sale in Canada in the medical and adult-use markets, and in select international jurisdictions. Its subsidiaries include Aleafia Inc., Canabo Medical Corporation, Aleafia Farms Inc., Emblem Corp., Emblem Cannabis Corporation, GrowWise Health Limited and other.


GREY:ALEAF - Post by User

Post by sthineion Jan 10, 2021 10:10am
409 Views
Post# 32262983

Best sector value out there

Best sector value out thereWhere to start. Aleaf has tolx us they have already booked 16 mln wholesale revs from their outdoor crop with majority to fall in December qtr. I estimate it is between 12-14 mln in revs. Just that alone is a sequential gain of 200 to 250% gain or yoy over 100 to 150% gain. No one else in industry doing those numbers right now. Next they have two medical fulfilment deals likely to fall in q1 for an additional 2500 of premium flower likely to sell between $5- $7 cdn. That alone is another $16 mln in revs in addition to more wholesale and their own direct to consumer sales. You are looking at well over $20 million in revs on q1 and likely profitability in that qtr especially after stripping out $500k in interest costs. Once again paying down debt with cash. Another rarity in this industry. Everyone else diluting shares with offerings to be used to pay debt. They likely have about 50k kilograms or more of product to sell thru in 2021. At an avg price of even $4 that amounts to $200 mln in revs. The market cap only $187. Compared to other competitors? Cgc trades at 20x revs, cronos at 9x, hexo 5x, acb 5x, apha 4x. Aleaf probably needs to do the reverse split this qtr to get nyse or nasdaq listing to get their stock price above $5 and get some real analyst, some etf sector holding etc...because they are indeed on the verge of posting best numbers across the sector and need to strike while the iron is hot.
<< Previous
Bullboard Posts
Next >>